Acceptability and tolerance of a low tyrosine and phenylalanine diet in patients with advanced cancer - A pilot study

Journal of Human Nutrition and Dietetics

Volumn 15, Issue 3, 2002, Pages 193-202

  Harvie, M N ^a,c   Campbell, I T ^a   Howell, A ^a   Thatcher, N ^b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

Cancer; Phenylalanine; Tolerance; Tyrosine

Indexed keywords

PHENYLALANINE; SERUM ALBUMIN; TRYPTOPHAN; TYROSINE;

ADULT; ADVANCED CANCER; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ANXIETY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BREAST CANCER; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIET THERAPY; ENERGY EXPENDITURE; FOOD COMPOSITION; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MELANOMA; METASTASIS; NEUTROPHIL; NUTRITIONAL STATUS; PILOT STUDY; PROTEIN RESTRICTION; QUALITY OF LIFE; WEIGHT REDUCTION;

ADULT; AGED; BREAST NEOPLASMS; DEPRESSION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NUTRITIONAL STATUS; PHENYLALANINE; PILOT PROJECTS; QUALITY OF LIFE; TREATMENT OUTCOME; TRYPTOPHAN; TYROSINE;

ANIMALIA;

EID: 0036077553     PISSN: 09523871     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-277X.2002.00365.x     Document Type: Article

References (30)

1. Differential growth factor production, secretion and response by high and low metastatic variants of B16BL6 melanoma
2. Plasma and CSF tryptophan in cancer anorexia
3. Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist
4. Effects of reducing the phenylalanine-tyrosine intake of patients with advanced malignant melanoma
5. Macronutrient requirements in the malnourished cancer patient. How much and what and why?
6. Albumin standards and the measurement of serum albumin with bromocresol green
7. Body fat assessed from total density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years
8. Reduced intake of phenylalaine and tyrosine as treatment of choroidal malignant melanoma
9. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo
10. Fat-free body mass from skinfold thickness: A close relationship with total body nitrogen
11. The clinical evaluation of chemotherapeutic agents in cancer
12. The effects of a phenylalanine and tyrosine restricted diet on elemental balance studies and plasma aminograms of patients with disseminated malignant melanoma
13. Melanoma: Chemotherapy
14. Serum amino acids in weight losing patients with cancer and tuberculosis
15. Manual immunoephelometric assay of proteins, with use of polymer enhancement
16. Response of malignancy to phenylalaine restriction
17. Tumour response to phenylalanine-tyrosine limited diets
18. Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet
19. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to cardio-levodopa methyl ester chemotherapy
20. Tyrosine and phenylalanine restricted formula diet augments immunocompetence in healthy humans
21. Effect of low phenylalanine diet on murine leukaemia L1210
22. Altered serum amino acid profiles in head and neck cancer
23. Low phenylalanine and tyrosine diet for malignant melanoma of the eye
24. The alternative dietary practice of a selected group of oncology patients receiving conventional medical treatment
25. Attachment, invasion, chemotaxis and proteinase expression of B16-BL6 melanoma cells exhibiting a low metastatic phenotype after exposure to dietary restriction of tyrosine and phenylalanine
26. Ibruprufen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic patients
27. The hospital anxiety and depression scale